• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程

Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

作者信息

Bairey Merz C Noel, Pepine Carl J, Walsh Mary Norine, Fleg Jerome L

机构信息

From Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Division of Cardiology, University of Florida, Gainesville (C.J.P.); St. Vincent Heart Transplant, Indianapolis, IN (M.N.W.); and National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F.).

出版信息

Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.

DOI:10.1161/CIRCULATIONAHA.116.024534
PMID:28289007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5385930/
Abstract

The Cardiovascular Disease in Women Committee of the American College of Cardiology, in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, American Heart Association, and European Society of Cardiology), convened a working group to develop a consensus on the syndrome of myocardial ischemia with no obstructive coronary arteries. In general, these patients have elevated risk for a cardiovascular event (including acute coronary syndrome, heart failure hospitalization, stroke, and repeat cardiovascular procedures) compared with reference subjects and appear to be at higher risk for development of heart failure with preserved ejection fraction. A subgroup of these patients also has coronary microvascular dysfunction and evidence of inflammation. This document provides a summary of findings and recommendations for the development of an integrated approach for identifying and managing patients with ischemia with no obstructive coronary arteries and outlines knowledge gaps in the area. Working group members critically reviewed available literature and current practices for risk assessment and state-of-the-science techniques in multiple areas, with a focus on next steps needed to develop evidence-based therapies. This report presents highlights of this working group review and a summary of suggested research directions to advance this field in the next decade.

摘要

美国心脏病学会女性心血管疾病委员会与相关方(来自美国国立心肺血液研究所、美国心脏协会和欧洲心脏病学会)联合召集了一个工作组,就无阻塞性冠状动脉的心肌缺血综合征达成共识。总体而言,与参照对象相比,这些患者发生心血管事件(包括急性冠状动脉综合征、心力衰竭住院、中风和重复心血管手术)的风险更高,并且发生射血分数保留的心力衰竭的风险似乎也更高。这些患者中的一个亚组还存在冠状动脉微血管功能障碍和炎症证据。本文档总结了研究结果,并就制定识别和管理无阻塞性冠状动脉缺血患者的综合方法提出了建议,同时概述了该领域的知识空白。工作组成员严格审查了现有文献以及多个领域风险评估和科学技术现状的当前实践,重点关注开发循证疗法所需的后续步骤。本报告介绍了该工作组成员审查的要点以及为在未来十年推动该领域发展而建议的研究方向总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/2d9ad452a52b/nihms850333f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/c207a96a014a/nihms850333f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/1907abce362d/nihms850333f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/72ae4c525071/nihms850333f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/2d9ad452a52b/nihms850333f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/c207a96a014a/nihms850333f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/1907abce362d/nihms850333f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/72ae4c525071/nihms850333f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/5385930/2d9ad452a52b/nihms850333f4.jpg

相似文献

1
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程
Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
2
Ischemia and no obstructive coronary arteries (INOCA): A narrative review.缺血但非阻塞性冠状动脉疾病(INOCA):一篇叙述性综述。
Atherosclerosis. 2022 Dec;363:8-21. doi: 10.1016/j.atherosclerosis.2022.11.009. Epub 2022 Nov 12.
3
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.一份由欧洲心脏病学会冠状动脉病理生理学与微循环工作组合作完成,并经冠状动脉血管舒缩障碍国际研究组认可的关于非阻塞性冠状动脉缺血的欧洲经皮心血管介入学会专家共识文件。
Eur Heart J. 2020 Oct 1;41(37):3504-3520. doi: 10.1093/eurheartj/ehaa503.
4
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.欧洲心脏病学会与冠状动脉病理生理学和微循环工作组合作的 EAPCI 专家共识文件,缺血与非阻塞性冠状动脉,由冠状动脉血管舒缩障碍国际研究小组认可。
EuroIntervention. 2021 Jan 20;16(13):1049-1069. doi: 10.4244/EIJY20M07_01.
5
Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).为何名称对女性至关重要:MINOCA/INOCA(心肌梗死/缺血且无阻塞性冠状动脉疾病)
Clin Cardiol. 2018 Feb;41(2):185-193. doi: 10.1002/clc.22894. Epub 2018 Mar 2.
6
Pathophysiology of coronary microvascular dysfunction.冠状动脉微血管功能障碍的病理生理学
Vascul Pharmacol. 2023 Dec;153:107239. doi: 10.1016/j.vph.2023.107239. Epub 2023 Oct 28.
7
[Optimizing the care management pathway of patients with ischemia and non-obstructive coronary arteries].[优化缺血性非阻塞性冠状动脉疾病患者的护理管理路径]
G Ital Cardiol (Rome). 2024 May;25(5):309-317. doi: 10.1714/4252.42294.
8
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
9
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).2018 年欧洲共识文件:急性冠状动脉综合征和/或经皮心血管介入治疗的心房颤动患者抗栓治疗管理:欧洲心律协会(EHRA)、欧洲心脏病学会血栓工作组、欧洲经皮心血管介入协会(EAPCI)和欧洲急性心脏护理协会(ACCA)的联合共识文件,得到了心律学会(HRS)、亚太心律学会(APHRS)、拉丁美洲心律学会(LAHRS)和南非心脏心律失常学会(CASSA)的认可。
Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174.
10
Ischemic Heart Disease in Young Women: JACC Review Topic of the Week.青年女性缺血性心脏病:JACC 本周综述主题。
J Am Coll Cardiol. 2022 Sep 6;80(10):1014-1022. doi: 10.1016/j.jacc.2022.01.057.

引用本文的文献

1
Right ventricular myocardial blood flow estimated by 13N-ammonia positron emission tomography in patients with coronary artery disease.用13N-氨正电子发射断层扫描估计冠心病患者的右心室心肌血流量。
EJNMMI Rep. 2025 Sep 8;9(1):32. doi: 10.1186/s41824-025-00265-5.
2
Ischemia with Non-Obstructive Coronary Artery Disease: Sex-Based Differences in Pathophysiology, Clinical Presentation, and Prognosis.非阻塞性冠状动脉疾病伴发的心肌缺血:病理生理学、临床表现及预后方面的性别差异
J Clin Med. 2025 Aug 14;14(16):5764. doi: 10.3390/jcm14165764.
3
Prevention and reversal of hypertension-induced coronary microvascular dysfunction by a plant-based diet.

本文引用的文献

1
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.欧洲心脏病学会工作组关于非阻塞性冠状动脉心肌梗死的立场文件。
Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149.
2
Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.因冠状动脉造影而接受检查的女性相对于男性存在额外的心血管风险,这与严重受损的冠状动脉血流储备有关,而非阻塞性疾病。
Circulation. 2017 Feb 7;135(6):566-577. doi: 10.1161/CIRCULATIONAHA.116.023266. Epub 2016 Nov 14.
3
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.
通过植物性饮食预防和逆转高血压引起的冠状动脉微血管功能障碍。
bioRxiv. 2025 Aug 6:2025.04.19.649660. doi: 10.1101/2025.04.19.649660.
4
Prognostic significance of cold pressor test myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.冷加压试验心肌灌注成像在缺血性非阻塞性冠状动脉疾病患者中的预后意义
Quant Imaging Med Surg. 2025 Aug 1;15(8):6763-6775. doi: 10.21037/qims-2025-33. Epub 2025 Jul 30.
5
Potential Role of N-NH Cardiac PET in Monitoring Treatment Response in Patients with Microvascular Angina.N-NH 心肌正电子发射断层显像在监测微血管性心绞痛患者治疗反应中的潜在作用
Indian J Nucl Med. 2025 Mar-Apr;40(2):103-105. doi: 10.4103/ijnm.ijnm_16_25. Epub 2025 Jun 27.
6
Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models.缺血性心脏病中的冠状动脉微血管功能障碍:来自大型动物模型的经验教训。
Basic Clin Pharmacol Toxicol. 2025 Aug;137(2):e70074. doi: 10.1111/bcpt.70074.
7
Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks.归因于生活方式和代谢风险的动脉粥样硬化性心血管疾病的全球负担。
Sci China Life Sci. 2025 Jun 23. doi: 10.1007/s11427-025-2948-y.
8
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference.在2025年美国心脏病学会会议上发表的心血管疾病预防研究亮点。
Curr Atheroscler Rep. 2025 Jun 21;27(1):67. doi: 10.1007/s11883-025-01313-y.
9
Global Trends in Ischemic Heart Disease-Related Mortality From 2000 to 2019.2000年至2019年缺血性心脏病相关死亡率的全球趋势。
JACC Adv. 2025 Jun 19;4(7):101904. doi: 10.1016/j.jacadv.2025.101904.
10
Matrine alleviates coronary microvascular dysfunction in ischemia with non-obstructive coronary artery disease mice induced by advanced glycation end products inhibition of the reactive oxygen species-mediated endoplasmic reticulum stress in cardiac microvascular endothelial cells.苦参碱通过抑制晚期糖基化终产物诱导的活性氧介导的心脏微血管内皮细胞内质网应激,减轻非阻塞性冠状动脉疾病小鼠缺血时的冠状动脉微血管功能障碍。
J Tradit Chin Med. 2025 Jun;45(3):473-484. doi: 10.19852/j.cnki.jtcm.2025.03.006.
无阻塞性冠状动脉疾病的心绞痛女性患者的冠状动脉微血管功能与心血管危险因素:iPOWER研究
J Am Heart Assoc. 2016 Mar 15;5(3):e003064. doi: 10.1161/JAHA.115.003064.
4
Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events.与标准临床风险评分相比,冠状动脉内皮功能检测在预测心血管事件方面具有更好的辨别能力。
Coron Artery Dis. 2016 May;27(3):213-20. doi: 10.1097/MCA.0000000000000347.
5
Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).无阻塞性冠状动脉疾病女性的主动脉僵硬度和波反射与冠状动脉血流储备的关联:来自美国国立心肺血液研究所资助的女性缺血综合征评估(WISE)的一项辅助研究。
Am Heart J. 2015 Dec;170(6):1243-54. doi: 10.1016/j.ahj.2015.08.019. Epub 2015 Aug 28.
6
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
7
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association.糖尿病心血管后果的性别差异:美国心脏协会的科学声明
Circulation. 2015 Dec 22;132(25):2424-47. doi: 10.1161/CIR.0000000000000343. Epub 2015 Dec 7.
8
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.一项关于晚期钠电流抑制药物(雷诺嗪)治疗冠状动脉微血管功能障碍(CMD)的随机、安慰剂对照试验:对心绞痛和心肌灌注储备的影响。
Eur Heart J. 2016 May 14;37(19):1504-13. doi: 10.1093/eurheartj/ehv647. Epub 2015 Nov 27.
9
Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.心肌脂肪变性作为女性舒张功能障碍与冠状动脉微血管功能障碍之间可能的机制联系。
Am J Physiol Heart Circ Physiol. 2016 Jan 1;310(1):H14-9. doi: 10.1152/ajpheart.00612.2015. Epub 2015 Oct 30.
10
Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.非阻塞性冠状动脉疾病的出现:女性问题以及血管造影定义需改变
J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33. doi: 10.1016/j.jacc.2015.08.876.